Akebia Therapeutics Inc
NASDAQ:AKBA

Watchlist Manager
Akebia Therapeutics Inc Logo
Akebia Therapeutics Inc
NASDAQ:AKBA
Watchlist
Price: 1.035 USD -5.91% Market Closed
Updated: May 28, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

225.5m
-7%
Assets
Growth Rates:
1 Year
-19%
3 Years
-64%
5 Years
-75%
7 Years
-13%
10 Years
+68%
252.7m
-7%
Liabilities
Growth Rates:
1 Year
-13%
3 Years
-39%
5 Years
-22%
7 Years
+11%
10 Years
+3 976%
-27.3m
+11%
Equity
Growth Rates:
1 Year
-89%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Akebia Therapeutics Inc

225.5m
Assets
252.7m
Liabilities
225.5m
Assets
252.7m
Liabilities
Current Assets 112.9m
Cash & Short-Term Investments 42m
Receivables 26.6m
Other Current Assets 44.4m
Non-Current Assets 112.5m
PP&E 14.7m
Intangibles 86.1m
Other Non-Current Assets 11.8m
Current Liabilities 66.5m
Accounts Payable 11.9m
Accrued Liabilities 53.9m
Other Current Liabilities 695k
Non-Current Liabilities 186.2m
Long-Term Debt 30.1m
Other Non-Current Liabilities 156.1m

Balance Sheet
Akebia Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
33
50
187
70
105
147
229
150
91
43
Cash Equivalents
33
50
187
70
105
147
229
150
91
43
Short-Term Investments
76
89
73
248
217
0
40
0
0
0
Total Receivables
0
0
34
34
17
39
27
52
40
39
Accounts Receivables
0
0
34
34
17
39
27
52
40
39
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
114
116
61
37
22
16
Other Current Assets
2
3
2
6
16
7
15
33
33
20
Total Current Assets
111
141
296
358
468
310
371
271
185
118
PP&E Net
0
1
3
4
8
39
36
41
34
16
PP&E Gross
0
1
3
4
8
39
36
41
0
0
Accumulated Depreciation
0
0
0
1
2
4
6
8
0
0
Intangible Assets
0
0
0
0
328
291
144
108
72
36
Goodwill
0
0
0
0
55
55
55
59
59
59
Other Long-Term Assets
0
1
1
2
137
76
38
50
5
12
Other Assets
0
0
0
0
55
55
55
59
59
59
Total Assets
111
N/A
143
+29%
300
+110%
364
+21%
997
+174%
771
-23%
644
-16%
529
-18%
356
-33%
242
-32%
Liabilities
Accounts Payable
2
2
2
7
43
39
41
34
18
15
Accrued Liabilities
5
10
30
52
151
129
131
109
76
68
Short-Term Debt
0
0
0
0
15
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
98
32
18
Other Current Liabilities
0
0
82
83
57
40
15
21
4
0
Total Current Liabilities
7
12
114
141
266
208
187
261
130
100
Long-Term Debt
0
0
0
0
0
76
96
0
34
17
Deferred Income Tax
0
0
0
0
7
0
0
0
0
0
Other Liabilities
0
0
118
101
88
93
113
194
187
155
Total Liabilities
7
N/A
12
+72%
232
+1 850%
242
+4%
361
+49%
376
+4%
397
+5%
455
+15%
351
-23%
272
-22%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
101
161
297
371
514
794
1 178
1 463
1 557
1 609
Additional Paid In Capital
205
293
365
494
1 151
1 189
1 425
1 537
1 562
1 578
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
104
N/A
131
+26%
68
-48%
123
+80%
636
+419%
395
-38%
248
-37%
74
-70%
5
-93%
31
N/A
Total Liabilities & Equity
111
N/A
143
+29%
300
+110%
364
+21%
997
+174%
771
-23%
644
-16%
529
-18%
356
-33%
242
-32%
Shares Outstanding
Common Shares Outstanding
20
31
39
48
117
122
148
177
184
195

See Also

Summary
AKBA intrinsic value, competitors valuation, and company profile.
DCF Valuation
AKBA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AKBA stock valuation using valuation multiples.
Wall Street Estimates
AKBA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AKBA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.